Clinical Trials Directory

Trials / Unknown

UnknownNCT02146469

Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
1,200 (estimated)
Sponsor
Shanghai Municipal Center for Disease Control and Prevention · Academic / Other
Sex
All
Age
1 Year – 7 Years
Healthy volunteers
Accepted

Summary

The objective of the study is as follows: 1. To know the antibody level during different interval after received 1 dose varicella vaccine. 2. To know safety and effectiveness of received 2 doses varicella vaccine with different interval. 3. To know safety and effectiveness of received varicella vaccine and MMR at the same time. To achieve that, this study selects children with specific varicella vaccine history, gives 1 or 2 doses varicella vaccine, collects blood specimens and makes a follow-up visit after vaccination. All blood specimens will be tested by a third-party detection institution.

Conditions

Interventions

TypeNameDescription
BIOLOGICAL2 doses with an 3 months intervalvaricella vaccination
BIOLOGICALA second dose with an 1 year intervalvaricella vaccine
BIOLOGICALA second dose with an 3 year intervalvaricella vaccine
BIOLOGICALA second dose with an 5 year intervalvaricella vaccine
BIOLOGICAL1 dose Varicella vaccine and 1 dose MMR given at the same timevaricella vaccine and MMR
BIOLOGICAL1 dose MMRMMR

Timeline

Start date
2012-12-01
Primary completion
2014-06-01
Completion
2014-12-01
First posted
2014-05-23
Last updated
2014-05-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02146469. Inclusion in this directory is not an endorsement.